← Browse by Condition
Medical Condition
myelodysplastic myeloproliferative neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05875805
Recruiting
A Telehealth Advance Care Planning Intervention
Enrollment
207 pts
Location
United States
Sponsor
University of Rochester
NCT07228624 Phase 2
Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Enrollment
50 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center